226 related articles for article (PubMed ID: 24296878)
41. Activated Hepatic Stellate Cells (HSCs) Exert Immunosuppressive Effects in Hepatocellular Carcinoma by Producing Complement C3.
Xu Y; Huang Y; Xu W; Zheng X; Yi X; Huang L; Wang Y; Wu K
Onco Targets Ther; 2020; 13():1497-1505. PubMed ID: 32110047
[TBL] [Abstract][Full Text] [Related]
42. Hepatocellular carcinoma-derived exosomal miRNA-21 contributes to tumor progression by converting hepatocyte stellate cells to cancer-associated fibroblasts.
Zhou Y; Ren H; Dai B; Li J; Shang L; Huang J; Shi X
J Exp Clin Cancer Res; 2018 Dec; 37(1):324. PubMed ID: 30591064
[TBL] [Abstract][Full Text] [Related]
43. Remodeling of hepatic stellate cells orchestrated the stroma-derived oxaliplatin-resistance through CCN3 paracrine in hepatocellular carcinoma.
Liao X; Bu Y; Chang F; Jia F; Song G; Xiao X; Zhang M; Ning P; Jia Q
BMC Cancer; 2019 Dec; 19(1):1192. PubMed ID: 31805888
[TBL] [Abstract][Full Text] [Related]
44. Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo.
Garcia MG; Bayo J; Bolontrade MF; Sganga L; Malvicini M; Alaniz L; Aquino JB; Fiore E; Rizzo MM; Rodriguez A; Lorenti A; Andriani O; Podhajcer O; Mazzolini G
Mol Pharm; 2011 Oct; 8(5):1538-48. PubMed ID: 21770423
[TBL] [Abstract][Full Text] [Related]
45. Deciphering the possible reciprocal loop between hepatic stellate cells and cancer cells in the tumor microenvironment of the liver.
Ezhilarasan D; Najimi M
Crit Rev Oncol Hematol; 2023 Feb; 182():103902. PubMed ID: 36621514
[TBL] [Abstract][Full Text] [Related]
46. A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells.
Hoechst B; Ormandy LA; Ballmaier M; Lehner F; Krüger C; Manns MP; Greten TF; Korangy F
Gastroenterology; 2008 Jul; 135(1):234-43. PubMed ID: 18485901
[TBL] [Abstract][Full Text] [Related]
47. Hepatic stellate cell and monocyte interaction contributes to poor prognosis in hepatocellular carcinoma.
Ji J; Eggert T; Budhu A; Forgues M; Takai A; Dang H; Ye Q; Lee JS; Kim JH; Greten TF; Wang XW
Hepatology; 2015 Aug; 62(2):481-95. PubMed ID: 25833323
[TBL] [Abstract][Full Text] [Related]
48. Regulatory T cells in chronic hepatitis B patients affect the immunopathogenesis of hepatocellular carcinoma by suppressing the anti-tumour immune responses.
Zhang HH; Mei MH; Fei R; Liu F; Wang JH; Liao WJ; Qin LL; Wei L; Chen HS
J Viral Hepat; 2010 Mar; 17 Suppl 1():34-43. PubMed ID: 20586932
[TBL] [Abstract][Full Text] [Related]
49. Selective expansion of allogeneic regulatory T cells by hepatic stellate cells: role of endotoxin and implications for allograft tolerance.
Dangi A; Sumpter TL; Kimura S; Stolz DB; Murase N; Raimondi G; Vodovotz Y; Huang C; Thomson AW; Gandhi CR
J Immunol; 2012 Apr; 188(8):3667-77. PubMed ID: 22427640
[TBL] [Abstract][Full Text] [Related]
50. Inhibition of Hepatic Stellate Cell Activation Suppresses Tumorigenicity of Hepatocellular Carcinoma in Mice.
Kang MJ; Lee S; Jung U; Mandal C; Park H; Stetler-Stevenson WG; Kim YS; Moon JW; Park SH; Oh J
Am J Pathol; 2021 Dec; 191(12):2219-2230. PubMed ID: 34428424
[TBL] [Abstract][Full Text] [Related]
51. PPP1R15A-expressing monocytic MDSCs promote immunosuppressive liver microenvironment in fibrosis-associated hepatocellular carcinoma.
Liu X; Liu M; Wu H; Tang W; Yang W; Chan TTH; Zhang L; Chen S; Xiong Z; Liang J; Wai-Yiu Si-Tou W; Shu T; Li J; Cao J; Zhong C; Sun H; Kwong TT; Leung HHW; Wong J; Bo-San Lai P; To KF; Xiang T; Jao-Yiu Sung J; Chan SL; Zhou J; Sze-Lok Cheng A
JHEP Rep; 2024 Jul; 6(7):101087. PubMed ID: 38882672
[TBL] [Abstract][Full Text] [Related]
52. Activated hepatic stellate cells promote hepatocellular carcinoma cell migration and invasion via the activation of FAK-MMP9 signaling.
Han S; Han L; Yao Y; Sun H; Zan X; Liu Q
Oncol Rep; 2014 Feb; 31(2):641-8. PubMed ID: 24284889
[TBL] [Abstract][Full Text] [Related]
53. MIRLET7BHG promotes hepatocellular carcinoma progression by activating hepatic stellate cells through exosomal SMO to trigger Hedgehog pathway.
Xia Y; Zhen L; Li H; Wang S; Chen S; Wang C; Yang X
Cell Death Dis; 2021 Mar; 12(4):326. PubMed ID: 33771969
[TBL] [Abstract][Full Text] [Related]
54. Subsets of myeloid-derived suppressor cells in hepatocellular carcinoma express chemokines and chemokine receptors differentially.
Zhao W; Xu Y; Xu J; Wu D; Zhao B; Yin Z; Wang X
Int Immunopharmacol; 2015 Jun; 26(2):314-21. PubMed ID: 25891236
[TBL] [Abstract][Full Text] [Related]
55. Icaritin Induces Anti-tumor Immune Responses in Hepatocellular Carcinoma by Inhibiting Splenic Myeloid-Derived Suppressor Cell Generation.
Tao H; Liu M; Wang Y; Luo S; Xu Y; Ye B; Zheng L; Meng K; Li L
Front Immunol; 2021; 12():609295. PubMed ID: 33717093
[TBL] [Abstract][Full Text] [Related]
56. CCL15 Recruits Suppressive Monocytes to Facilitate Immune Escape and Disease Progression in Hepatocellular Carcinoma.
Liu LZ; Zhang Z; Zheng BH; Shi Y; Duan M; Ma LJ; Wang ZC; Dong LQ; Dong PP; Shi JY; Zhang S; Ding ZB; Ke AW; Cao Y; Zhang XM; Xi R; Zhou J; Fan J; Wang XY; Gao Q
Hepatology; 2019 Jan; 69(1):143-159. PubMed ID: 30070719
[TBL] [Abstract][Full Text] [Related]
57. Regression of established hepatocellular carcinoma is induced by chemoimmunotherapy in an orthotopic murine model.
Avella DM; Li G; Schell TD; Liu D; Zhang SS; Lou X; Berg A; Kimchi ET; Tagaram HR; Yang Q; Shereef S; Garcia LS; Kester M; Isom HC; Rountree CB; Staveley-O'Carroll KF
Hepatology; 2012 Jan; 55(1):141-52. PubMed ID: 21898502
[TBL] [Abstract][Full Text] [Related]
58. Peritumoral activated hepatic stellate cells predict poor clinical outcome in hepatocellular carcinoma after curative resection.
Ju MJ; Qiu SJ; Fan J; Xiao YS; Gao Q; Zhou J; Li YW; Tang ZY
Am J Clin Pathol; 2009 Apr; 131(4):498-510. PubMed ID: 19289585
[TBL] [Abstract][Full Text] [Related]
59. CCN1/Cyr61 enhances the function of hepatic stellate cells in promoting the progression of hepatocellular carcinoma.
Li ZQ; Wu WR; Zhao C; Zhao C; Zhang XL; Yang Z; Pan J; Si WK
Int J Mol Med; 2018 Mar; 41(3):1518-1528. PubMed ID: 29286082
[TBL] [Abstract][Full Text] [Related]
60. Group-2 Innate Lymphoid Cells Promote HCC Progression Through CXCL2-Neutrophil-Induced Immunosuppression.
Xu X; Ye L; Zhang Q; Shen H; Li S; Zhang X; Ye M; Liang T
Hepatology; 2021 Nov; 74(5):2526-2543. PubMed ID: 33829508
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]